All Updates

All Updates

icon
Filter
Partnerships
GRAIL, Whitman-Walker Institute, and Cancer Support Community partner to study health equity in cancer
Precision Medicine
Aug 23, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Precision Medicine

Precision Medicine

Aug 23, 2023

GRAIL, Whitman-Walker Institute, and Cancer Support Community partner to study health equity in cancer

Partnerships

  • Genetic testing company GRAIL has partnered with non-profits Whitman-Walker Institute and Cancer Support Community (CSC) on a study aimed at advancing health equity in cancer screening and care using GRAIL's multi-cancer early detection (MCED) test.

  • The collaboration aims to increase early cancer screening in underrepresented populations, assess the feasibility of using GRAIL’s test in diverse patient populations, and increase access to MCED testing in diverse communities. In addition, participants who receive a positive result from the Galleri test will be offered support and navigation services from diagnosis through treatment by CSC.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.